The University of Texas MD Anderson Cancer Center is a comprehensive cancer center and part of the University of Texas System, headquartered in Houston, Texas. Established in 1941, it focuses on cancer patient care, research, education and prevention as a non-profit institution. It operates as one of the largest centers for cancer clinical trials worldwide and maintains affiliations with the National Cancer Institute.
Also known as UT MD Anderson, University of Texas MD Anderson Cancer Center, and MD Anderson Cancer Center.
None yet. When a new project in the record names MD Anderson as owner, partner or investor, it shows here.
First FDA-cleared IHC companion diagnostic to detect PTEN protein loss and select patients for capivasertib (TRUQAP) plus abiraterone therapy.
